What is Morepen Laboratories Ltd. Quarterly Revenue?

Morepen Laboratories Ltd. Quarterly Revenue Morepen Laboratories Jun-2026 Quarterly Revenue is Rs 546 Cr which is growth of 38.2% YoY.

What is Morepen Laboratories Ltd. Quarterly Net Profit?

Morepen Laboratories Ltd. Quarterly Net Profit Morepen Laboratories Jun-2026 Quarterly Net Profit is Rs 54 Cr which is growth of 569.9% YoY.

What is Morepen Laboratories Ltd. Annual Revenue?

Morepen Laboratories Ltd. Annual Revenue Morepen Laboratories Mar-2026 Annual Revenue is Rs 1,703 Cr which is growth of 8.4% YoY.

What is Morepen Laboratories Ltd. Annual Net Profit?

Morepen Laboratories Ltd. Annual Net Profit Morepen Laboratories Mar-2026 Annual Net Profit is Rs 66 Cr which is growth of -35.0% YoY.

What is Morepen Laboratories Ltd. Total Shareholders Fund?

Morepen Laboratories Ltd. Total Shareholders Fund Morepen Laboratories Mar-2026 Total Shareholders Fund is Rs 1,243 Cr which is growth of 5.2% YoY.

What is Morepen Laboratories Ltd. Total Assets?

Morepen Laboratories Ltd. Total Assets Morepen Laboratories Mar-2026 Total Assets is Rs 1,908 Cr which is growth of 10.8% YoY.

What is Morepen Laboratories Ltd. Book Value Per Share?

Morepen Laboratories Ltd. Book Value Per Share Morepen Laboratories Mar-2026 Book Value Per Share is 23 Rs which is growth of 5.2% YoY.

What is Morepen Laboratories Ltd. ROE?

Morepen Laboratories Ltd. ROE Morepen Laboratories Mar-2026 ROE is 5% which is growth of 3.3% YoY.

What is Morepen Laboratories Ltd. Cash From Operating Activity?

Morepen Laboratories Ltd. Cash From Operating Activity Morepen Laboratories Mar-2026 Cash From Operating Activity is Rs 20 Cr which is growth of -29.6% YoY.

What is Morepen Laboratories Ltd. Net Cash Flow?

Morepen Laboratories Ltd. Net Cash Flow Morepen Laboratories Mar-2026 Net Cash Flow is Rs -1 Cr which is growth of -115.7% YoY.

Morepen Laboratories Ltd.

NSE: MOREPENLAB | BSE: 500288|

Strong Performer, Getting Expensive

Download real time

-1.73(-1.38%)

274.80% Gain from 52W Low

2.9M

NSE+BSE Volume

NSE 16 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Morepen Laboratories quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Morepen Laboratories quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue Morepen Laboratories Jun-2026 Quarterly Revenue is Rs 546 Cr which is growth of 38.2% YoY.
POSITIVE
Quarterly Net Profit Morepen Laboratories Jun-2026 Quarterly Net Profit is Rs 54 Cr which is growth of 569.9% YoY.

Morepen Laboratories Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
Indicator	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23	Jun '23
TOTAL_SR_Q Total Rev. ⌄	546.4	471.6	461.5	374.2	395.4	385.1	408.1	388.3	388.7	396.6	398.3	384.1	371.2
SR_Q Operating Rev.	541	462.8	457.6	369.5	391.3	381.9	403.3	383.7	385.6	392.6	394.6	381.3	369.1
OI_Q Other Income	5.3	8.8	3.9	4.7	4.1	3.1	4.9	4.6	3.1	4	3.7	2.8	2.1
OEXPNS_Q Operating Exp.	461.4	439.5	415.7	341.6	372.3	351.8	371.7	340.6	337	336.5	343.5	351.5	344.3
OEXPNS_Q Operating Exp.	461.4	439.5	415.7	341.6	372.3	351.8	371.7	340.6	337	336.5	343.5	351.5	344.3
OP_Q Operating Profit	79.6	23.3	41.9	27.9	19	30.2	31.6	43.1	48.6	56.1	51.1	29.8	24.8
OPMPCT_Q Operating Profit Margin %	14.71%	5.04%	9.15%	7.56%	4.84%	7.90%	7.83%	11.22%	12.60%	14.30%	12.95%	7.81%	6.72%
DEP_Q Depr.	8	0.6	10.1	10.7	7.9	12.3	4.8	3.8	3.6	6.7	5.5	4.8	4.9
INT_Q Interest	4.8	3.9	4.3	4.1	3.8	3.7	1.3	1.1	1	0.7	2	0.5	0.3
PBT_Q Profit Before Tax	72.2	27.6	31.4	18.9	11.4	17.3	30.4	42.9	47.1	52.7	47.2	27.3	21.7
TAX_Q Tax	18.2	7.5	7.9	4.5	3.3	5.4	7.7	10.9	12	12.8	12	7.4	5.9
NP_Q Net Profit	54	20.1	23.5	14.4	8.1	11.9	22.7	31.9	35.1	40	35.2	19.9	15.9
EPS_adj_Q EPS Adj. latest	1	0.4	0.4	0.3	0.2	0.2	0.4	0.6	0.6	0.7	0.6	0.4	0.3
NP_TTM Net profit TTM	112	66.1	57.9	57	74.6	101.6	129.6	142.1	130.1	110.9	81.3	58.6	55.2
EPS_TTM Basic EPS TTM	2	1.2	1.1	1	1.4	1.9	2.4	2.6	2.6	2.2	1.6	1.2	1.1
earnings_transcripts Earnings Transcripts
ai_summary AI Summary
results_pdf Results PDF
result_notes Result Notes	Notes	Notes	Notes	Notes	Notes		Notes	Notes	Notes	Notes	Notes	Notes	Notes

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Morepen Laboratories competitor comparison and performance snapshot within industry

Morepen Laboratories annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Morepen Laboratories Mar-2026 Annual Revenue is Rs 1,703 Cr which is growth of 8.4% YoY.
NEGATIVE
Annual Net Profit Morepen Laboratories Mar-2026 Annual Net Profit is Rs 66 Cr which is growth of -35.0% YoY.

Morepen Laboratories Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17
SR_A Total Rev. Ann. ⌄	8.2%	8.7%	1,853.7	1,702.7	1,570.3	1,550.2	1,344.6	1,459.5	1,124.2	801.4	720.9	564.4	551.2
TotalOperatingRevenues_A Operating Rev. Ann.	7.9%	8.6%	1,831	1,681.2	1,554.5	1,537.6	1,338.9	1,449.3	1,112.4	792	717.2	560.8	547.5
OI_A Other Income Ann.	54.8%	12.7%	22.7	21.5	15.7	12.6	5.8	10.2	11.8	9.4	3.7	3.5	3.7
OEXPNS_A Operating Exp. Ann.	7.5%	9.4%	1,658.2	1,569.1	1,401.1	1,375.8	1,261.6	1,320.1	1,000.1	727.5	652.2	500.6	487
OEXPNS_A Operating Exp. Ann.	7.5%	9.4%	1,658.2	1,569.1	1,401.1	1,375.8	1,261.6	1,320.1	1,000.1	727.5	652.2	500.6	487
OP_A Operating Profit Ann.	13.2%	-0.1%	172.7	112.1	153.4	161.8	77.3	129.1	112.4	64.5	65	60.3	60.5
OPMPCT_A OPM Ann. %	4.6%	-8%		6.58%	9.77%	10.44%	5.75%	8.85%	10.00%	8.04%	9.02%	10.68%	10.97%
TotalExpenses_A Total Exp. Ann. ⌄	8%	9.4%		1,614.5	1,432.7	1,401.2	1,281.6	1,334	1,030	763.9	692.3	538.3	528.1
OtherExpenses_A Other Exp. Ann.	12.4%	16.5%	239.5	301.5	248.3	265.2	212.4	179.6	140.2	108.4	101.1	89.7	90.5
EmployeeBenefitExpenses_A Employee Exp. Ann.	12.2%	10.9%	215.4	206.3	177.2	160.3	146.2	150	123.2	98.1	84.7	68.2	60.8
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-	47.1
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	17.2%	1.5%		133.6	169.1	174.4	83	139.4	124.2	73.9	68.7	63.8	64.2
EBIDTPCT_A EBITDA Ann. margin %	8.3%	-6.6%		7.84%	10.77%	11.25%	6.17%	9.55%	11.04%	9.22%	9.53%	11.31%	11.65%
INT_A Interest Ann.	100.4%	55%	17.1	16.1	7.1	3.5	2	-7.4	1.8	2	2.1	4.3	7.5
DEP_A Depr.	17.6%	0.8%	29.4	29.3	24.4	21.9	18	21.2	28.1	34.4	38	33.4	33.6
PBT_A PBT Ann.	12.3%	-1.1%	150.1	89.3	137.6	149	63	125.5	94.3	37.5	28.6	26.1	23.2
TAX_A Tax Ann.	11.4%	-	38.1	23.2	36	38	16.8	24.5		5.2
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	12.7%	-6.9%		66.1	101.6	110.9	46.2	101.1	94.3	32.3	28.6	26.1	23.2
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-		-	-	-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	12.7%	-6.9%	112	66.1	101.6	110.9	46.2	101.1	94.3	32.3	28.6	26.1	23.2
NETPCT_A NPM Ann. %	4.3%	-14.3%		3.92%	6.53%	7.21%	3.45%	6.97%	8.47%	4.08%	3.98%	4.65%	4.23%
EPS_adj_A EPS Adj. latest Ann.	14.5%	-6.7%		1.2	1.9	2	0.8	1.8	1.7	0.6	0.5	0.5	0.4
result_notes Result Notes				Notes		Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes
Annual_Reports Annual Reports

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

8.4%

2Y CAGR

4.8%

3Y CAGR

8.2%

5Y CAGR

8.7%

7Y CAGR

13.1%

Total Revenue Annual growth is stable compared to historical averages.

Net Profit Ann.

1Y CHG

-34.9%

2Y CAGR

-22.8%

3Y CAGR

12.7%

5Y CAGR

-6.9%

7Y CAGR

12.7%

Net Profit Annual is falling faster than historical averages.

Operating Exp. Ann.

1Y CHG

12%

2Y CAGR

6.8%

3Y CAGR

7.5%

5Y CAGR

9.4%

7Y CAGR

13.4%

Operating Expenses Annual Cr growth is stable compared to historical averages.

Morepen Laboratories balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Morepen Laboratories Mar-2026 Total Shareholders Fund is Rs 1,243 Cr which is growth of 5.2% YoY.
POSITIVE
Total Assets Morepen Laboratories Mar-2026 Total Assets is Rs 1,908 Cr which is growth of 10.8% YoY.

Morepen Laboratories Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	16.8%	25.4%	1,242.8	1,181.5	889	780.1	598.2	401.2	307.3	277.5	250.6	224.3
EQCAP_A Equity Share Capital Ann.	2.4%	4%	109.6	109.6	102.2	102.2	95.6	90	90	90	90	90
TotalShareCapital_A Total Share Capital Ann.	2.4%	4%	109.6	109.6	102.2	102.2	95.6	90	90	90	90	90
ReservesAndSurplus_A Reserves Plus Surplus Ann.	18.7%	29.5%	1,133.2	1,071.9	786.8	677.9	502.6	311.3	217.3	187.5	160.6	134.4
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	18.7%	29.5%	1,133.2	1,071.9	786.8	677.9	502.6	311.3	217.3	187.5	160.6	134.4
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	75.8%	47.5%	187.5	78.2	37.7	34.5	32.4	26.9	25.4	21.1	17.9	15.3
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	82.8%	-	16.5	7	2.3	2.7	2.5
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	23.9%	12.6%	3.8	9	0.4	2	2	2.1	2.1	1.5	1.7	1.7
CL_A Total Current Liabilities Ann. ⌄	17.9%	4.9%	477.4	461.6	352.6	291	402.7	375.6	329.4	320.8	322.2	308.2
TradePayables_A Trade Payables Ann.	3.6%	4.3%	236.8	338.4	267.4	213.1	217.3	192.3	158.4	157.1	164.9	116.2
OtherCurrentLiabilities_A Other Current Liabilities Ann.	64.4%	0.9%	171.8	52.3	37.3	38.7	158.5	164.4	157.4	153.6	36.4	71.1
ShortTermProvisions_A ST Provisions Ann.	-18.7%	17.3%	8	17.6	23.1	14.9	9.6	3.6	2.3	1.1	1.3	1.3
TL_A Total Capital Plus Liabilities Ann.	19.9%	17.6%	1,907.7	1,721.2	1,279.3	1,105.5	1,033.3	847.5	662	619.4	590.7	547.8
FixedAssets_A Fixed Assets Ann. ⌄	29.8%	23%	410.9	394.2	241	187.8	170.3	146	134.8	152.6	182.1	191.3
TangibleAssets_A Tangible Assets Ann.	24.2%	20%	318.4	332.3	212.4	166.1	145.4	127.9	132.4	145.4	170.1	190.9
IntangibleAssets_A Intangible Assets Ann.	161.8%	39.3%	84.3	33.6	4.1	4.7	10.7	16.1	2.4	7.2	12	0.5
CapitalWorkInProgress_A Capital Work In Progress Ann.	-21.6%	32.6%	8.2	28.3	24.5	17	14.2	2
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	21.3%	13.5%	669.2	614.4	436.4	374.7	356.5	354.7	313.7	336.1	359.9	369.3
NonCurrentInvestments_A Non Current Investments Ann.	-4%	-2.6%	104.1	127.2	126.2	117.8	117.8	118.8	118.8	117.7	117.7	117.7
DeferredTaxAssets_A Deferred Tax Assets Ann.	-	-
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	0%	0%	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0.3
OtherNonCurrentAssets_A Other Non Current Assets Ann.	30.7%	11.4%	154.1	92.9	69.2	69	68.4	89.9	60	65.7	60	60
CA_A Total Current Assets Ann. ⌄	19.2%	20.2%	1,238.5	1,106.8	842.9	730.9	676.8	492.8	348.3	283.3	230.8	178.6
CurrentInvestments_A Current Investments Ann.	-	-	5.9	77.8						0	0.2
TradeReceivables_A Trade Receivables Ann.	9.3%	16.5%	333.2	293.8	316.9	255.5	221.9	155.5	121.4	122	110.2	83.1
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	-5.6%	-6.8%	47	46.3	50.5	55.9	45.6	67	38	32	5.7	6.8
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	0%	0%	0.3	0.5	0.2	0.3	0.3	0.3	0.4	0.4	0.5	0.3
OtherCurrentAssets_A Other Current Assets Ann.	49.7%	47.4%	697.8	402	255.2	207.9	150.8	100.4	56	38.2	40.3	25.9
TA_A Total Assets Ann.	19.9%	17.6%	1,907.7	1,721.2	1,279.3	1,105.5	1,033.3	847.5	662	619.4	590.7	547.8
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	206.9%	151.4%	341.2	35.7	20	11.8	19	3.4	1.3	11.5
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	-	-
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	-4%	-2.4%	104.1	127.2	126.2	117.8	117.8	117.7	117.7	117.7	117.7	117.7
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	-	-

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

10.8%

2Y CAGR

22.1%

3Y CAGR

19.9%

5Y CAGR

17.6%

7Y CAGR

17.4%

Total Assets Annual growth is lower than historical averages.

Total Current Liabilities Ann.

1Y CHG

3.4%

2Y CAGR

16.4%

3Y CAGR

17.9%

5Y CAGR

4.9%

7Y CAGR

5.8%

Total Current Liabilities Annual Cr growth is lower than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

5.2%

2Y CAGR

18.2%

3Y CAGR

16.8%

5Y CAGR

25.4%

7Y CAGR

23.9%

Total ShareHolders Funds Annual growth is lower than historical averages.

Morepen Laboratories ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share Morepen Laboratories Mar-2026 Book Value Per Share is 23 Rs which is growth of 5.2% YoY.
POSITIVE
ROE Morepen Laboratories Mar-2026 ROE is 5% which is growth of 3.3% YoY.

Morepen Laboratories Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17
BVSH_A BVSH Ann.	14.1%	20.6%	22.7	21.6	17.4	15.3	12.5	8.9	6.8	6.2	5.6	5
ROA_A RoA Ann. %	-6.1%	-20.8%	3.46%	5.90%	8.67%	4.18%	9.78%	11.12%	4.88%	4.61%	4.42%	4.22%
ROE_A ROE Ann. %	-3.6%	-25.7%	5.31%	8.59%	12.47%	5.92%	16.89%	23.49%	10.52%	10.31%	10.42%	10.32%
ROCE_A ROCE Ann. %	-3%	-18.6%	7.28%	11.48%	16.45%	7.98%	18.74%	20.35%	11.86%	10.27%	11.32%	12.78%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	8.6%	-6.6%	7.94%	10.87%	11.34%	6.20%	9.61%	11.16%	9.32%	9.57%	11.37%	11.72%
PBITMargin_A EBIT Ann. Margin %	8.5%	-6.4%	6.20%	9.30%	9.91%	4.85%	8.15%	8.63%	4.98%	4.27%	5.42%	5.59%
PBTMargin_A PBT Ann. Margin %	4.1%	-9%	5.30%	8.85%	9.68%	4.70%	8.66%	8.47%	4.73%	3.98%	4.65%	4.23%
NETPCT_A NPM Ann. %	4.3%	-14.3%	3.92%	6.53%	7.21%	3.45%	6.97%	8.47%	4.08%	3.98%	4.65%	4.23%
ASETTO_A Asset Turnover Ann. %	-11.5%	-9.7%	0.9	1	1.3	1.3	1.5	1.5	1.2	1.2	1	1
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	1.3%	14.9%	2.6	2.4	2.4	2.5	1.7	1.3	1.1	0.9	0.7	0.6
QuickRatio_A Quick Ratio Ann.	8.5%	20.6%	2.3	1.8	1.8	1.8	1	0.9	0.7	0.6	0.5	0.4
DividendPayoutNP_A Dividend Payout to NP Ann.	-	-	0.2
EarningRetention_A Earning Retention Ann. %	-	-	83.57%
CashEarningRetention_A Cash Earning Retention Ann. %	-	-	88.62%
CashEarningRetention_A Cash Earning Retention Ann. %	-	-	88.62%
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	16%	7.5%	1,998.6	2,654.4	2,127.6	1,281.9	1,721.7	1,395.3	403.4	754.7	1,504.3	968.5
EVPerNetSales_A EV Per Net Sales Ann.	6.3%	-1.6%	1.2	1.7	1.4	1	1.2	1.3	0.5	1.1	2.7	1.8
PBV_A Price To Book Value Adjusted	-12.4%	-17%	5.46	5.91	7.12	8.12	9.89	13.89	18.13	20.08	22.24	24.83
EVPerEBITDA_A EV Per EBITDA Ann.	-0.9%	6%	15	15.7	12.2	15.4	12.4	11.2	5.5	11	23.6	15.1
MarketCapPerSales_A Market Cap Per Sales Ann.	3.2%	-3.3%	1.1	1.7	1.4	1	1.2	1.3	0.5	1.1	2.5	1.6
RetentionRatios_A Retention Ratio Ann. %	-	-	83.56%
EYield_A Earnings Yield Ann.	-	-	0	0	0.1	0	0.1	0.1	0.1	0	0	0
DEBT_CE_A Total Debt to Total Equity Ann.	-	-	0.2	0.1	0	0	0	0	0	0	0.5	0.5

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

ROE Ann. %

1Y CHG

-38.2%

2Y CAGR

-34.7%

3Y CAGR

-3.6%

5Y CAGR

-25.7%

7Y CAGR

-9%

ROE Annual % is falling faster than historical averages.

RoA Ann. %

1Y CHG

-41.4%

2Y CAGR

-36.8%

3Y CAGR

-6.1%

5Y CAGR

-20.8%

7Y CAGR

-4%

RoA Annual % is falling faster than historical averages.

Current Ratio Ann.

1Y CHG

8.3%

2Y CAGR

4.1%

3Y CAGR

1.3%

5Y CAGR

14.9%

7Y CAGR

16.4%

Current Ratio Annual growth is stable compared to historical averages.

Morepen Laboratories cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Cash From Operating Activity Morepen Laboratories Mar-2026 Cash From Operating Activity is Rs 20 Cr which is growth of -29.6% YoY.
NEGATIVE
Net Cash Flow Morepen Laboratories Mar-2026 Net Cash Flow is Rs -1 Cr which is growth of -115.7% YoY.

Morepen Laboratories Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17
CFO_A Cash from Operating Act. Ann. ⌄	-	-16.1%	20.5	29.1	77.4	-102.1	-66.4	49.3	10.9	14.6	61.3	49.2
PBT_A PBT Ann.	12.3%	-1.1%	89.3	137.6	149	63	125.5	94.3	37.5	28.6	26.1	23.2
INT_A Interest Ann.	100.4%	55%	16.1	7.1	3.5	2	-7.4	1.8	2	2.1	4.3	7.5
TAX_A Tax Ann.	11.4%	-	23.2	36	38	16.8	24.5		5.2
CFI_A Cash from Investing Act. Ann.	-	-	-119	-280.4	-83.6	-36.2	-22.6	-69.1	-12.1	-10.3	-24.3	-14.7
CFA_A Cash from Financing Act. Ann.	-12.4%	15.4%	97.1	260.5	0.3	144.2	63.9	47.5	4.7	-0.4	-37.7	-31.3
NCF_A Net Cash Flow Ann. ⌄	-	-	-1.4	9.1	-6	5.9	-25.1	27.7	3.4	3.9	-0.7	3.3
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	16.6%	13.8%	24.4	15.3	21.3	15.4	40.5	12.8	9.4	5.5	6.2	2.9
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	2.6%	-10.7%	23	24.4	15.3	21.3	15.4	40.5	12.8	9.4	5.5	6.2

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

-29.6%

2Y CAGR

-48.5%

5Y CAGR

-16.1%

7Y CAGR

Cash from Operating Activity Annual is falling faster than historical averages.

Cash from Financing Act. Ann.

1Y CHG

-62.7%

2Y CAGR

1699.1%

3Y CAGR

-12.4%

5Y CAGR

15.4%

Cash from Financing Annual Activity is falling faster than historical averages.

Morepen Laboratories investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow
Documents

274.80% Gain from 52W Low

Morepen Laboratories quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents